Bridgewater, NJ, United States of America

Sunghae Park

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Bridgewater, NJ (US) (2017 - 2022)
  • Waban, MA (US) (2020 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Sunghae Park**

Introduction

Sunghae Park is a distinguished inventor based in Bridgewater, NJ, USA. With a remarkable portfolio of eight patents, he has made significant contributions to the fields of biotechnology and therapeutics. His innovative work primarily focuses on antibodies aimed at combating critical viral infections and enhancing drug delivery systems.

Latest Patents

Among Sunghae Park's notable achievements are his latest patents. One significant invention is titled "Anti-CHIKV antibodies and uses thereof." This patent involves antibodies and antigen-binding fragments that specifically target and neutralize the Chikungunya virus (CHIKV). The invention aims to develop therapeutics to treat CHIKV disease or prevent infection with CHIKV. Additionally, it includes pharmaceutical compositions that utilize these antibodies for the prevention and treatment of CHIKV disease.

Another groundbreaking invention by Park is the "Bone-targeting antibodies." This patent describes recombinant and chemically-conjugated antibodies modified with poly-aspartate peptides to enhance their localization to bone tissue. It also unveils methods for the production and application of these antibodies and fragments, offering new avenues for targeted therapies.

Career Highlights

Sunghae Park has collaborated with renowned companies in the biotechnology sector, including Genzyme Corporation and Sanofi. These organizations have provided valuable platforms for him to contribute his expertise in antibody engineering and therapeutic development.

Collaborations

Throughout his career, Sunghae Park has worked alongside esteemed colleagues such as Huawei Qiu and Cendrine Lemoine. Their collaborative efforts have further advanced the understanding and application of antibodies in innovative therapeutic solutions.

Conclusion

Sunghae Park's contributions to the field of biotechnology through his inventive patents highlight his role as a leading figure in scientific innovation. His work not only enhances our understanding of viral infections but also opens up possibilities for novel treatments and better patient outcomes. As the industry evolves, Park's innovations will undoubtedly continue to play a pivotal role in shaping the future of therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…